Administration last year to approve semaglutide for use in children 12 years and older. 10,11 A recent Nature review argued that it's the first medical intervention for pediatric obesity that not only results in weight loss but also improves cardiometabolic risk factors and quality of life. 12 One reason researchers have been trying to create successful interventions for weight loss is that obesity is so bad for health, especially in the long term. Behavioral interventions keep getting more and more complicated because they don't work well, except in extreme circumstances, and often in ways that defy implementation. Maybe it's time to stop focusing on them. While I applaud the authors of this article for their efforts, there's a part of me that hopes this is the last such study I'll need to review.